Last reviewed · How we verify
Zoryve
At a glance
| Generic name | Zoryve |
|---|---|
| Sponsor | Padagis LLC |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Safety and Efficacy of Roflumilast Foam in HS (PHASE2)
- Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis (PHASE3)
- Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study (PHASE3)
- Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis (PHASE3)
- Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |